chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I just want to know if I got this shot too soon because I did have COVID last month; I just want to know if I got this shot too soon because I did have COVID last month; Feeling numb; too tired; My body is aching; I don't feel good; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "COVID" (unspecified if ongoing), notes: I just want to know if I got this shot too soon because I did have COVID last month. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1, Lot number: Unknown), for COVID-19 immunization; Bnt162b2 (Dose: 2, Lot number: Unknown), for COVID-19 immunization.  The following information was reported: OFF LABEL USE (non-serious), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious), outcome "unknown" and all described as "I just want to know if I got this shot too soon because I did have COVID last month"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "Feeling numb"; FATIGUE (non-serious), outcome "unknown", described as "too tired"; PAIN (non-serious), outcome "unknown", described as "My body is aching"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "I don't feel good".  Additional Information: Consumer stated, "I got your number on the paper from when I got the Pfizer booster shot and I was just calling to confirm some side effects. "I just want to know if I got this shot too soon because I did have COVID last month but, and I did have (incomplete sentence). I took the Pfizer both shots like a year ago like in April and then I got both shot (COVID-19 vaccine) and then I got booster now but I did have COVID last month, I was down for like a week." Consumer was informed about the role of Pfizer Drug Safety Department. Consumer further stated, "Okay. You know, I don't know how many days should I wait to be like, feeling numb, too tired and my body is aching. It was Friday after the shot and now Sunday morning you know, I didn't go to work yesterday and then today I woke up and it was not as bad but it is still, I don't feel good. So, I am wondering how many days should I expect to not to feel down and tired you know after this shot?"  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I was expected to have an allergic reaction to the vaccine from my prior VAERS report on my 1st and 2nd doses. I was told by my PCP to take Prednisone to help with symptoms. Within an hour I got a itching and burning sensation. I looked at my face. It was covered in hives. My left eye was swollen, and the right eye was blood red. My eyelids were swollen and in pain and inflamed. My throat was itching and seemed to be swelling. I called my doctor and the recommended I see a eye doctor. I waited two weeks and saw on in November 2021. Every week after the third dose, I have been experiencing issues that are worsening and new, migraines, red itchy eyes, swelling in my ears and throat. I see an allergy specialist- because I get all the symptoms from the throat up. My ear has even swollen. Recently, I had another flare up on 1-24-2022. My nose ears and eyes were swelling. My nose was draining. My doctor saw a patch of swelling in my throat. I am now seeing three specialist for my allergies and these reoccurring symptoms. I am being told I can not be allergy tested for the vaccine to receive a allergy blocker for the allergy in the vaccine, due to the fact the vaccine is a trial. I had got tested for COVID at my job, and I had COVID.
Golf ball sized lump in left armpit for 6 days. Also on day 2 post vaccine a horrible cold with cough  & fever of 101.5 lasted for 2 days. Has had a cough & cold for over 8 days now.
Dizziness, Headache, Myalgia, Fever & Nausea Vomiting  Narrative:
Approximately 2-3 days after the 1st dose, I had a colitis flare-up (I had not had any symptoms nor had any medication for the prior 2 years after changing my diet). I had leftover prescription medication, so I took it through 5/10/21 (2nd vaccination date) to counteract another possible autoimmune trigger from the 2nd vaccination. After quitting the prescription medication, I had no symptoms for 2 months.  A new colitis flare up began at the beginning of August 2021.  I went back on the prescription meds, but continue to have colitis symptoms.  My G.I doctor cannot get me an appointment until October 14, 2021, so I have not had a doctor examine me yet.
feeling strange; ill; headache; chills; intestinal issues; tiredness; nausea; This is a spontaneous report from a contactable Consumer (patient herself). A 65-year-old female non pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: unknown) via left arm on 09Feb2021 11:00, as a single dose for COVID-19 immunization in hospital. Patient's medical history included Multiple myeloma (in remission for the past seven years) and hemochromatosis. Concomitant medication include verapamil and reyvow. On 09Feb2021 12:00, the patient started feeling strange within one hour from receiving the vaccination. As the day progressed, the patient became ill and experienced horrible headache, chills, intestinal issues, tiredness nausea. Patient did not receive any treatment for the adverse event. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination was not diagnosed with COVID-19. Since the vaccination patient had not tested for COVID-19. Patient had not allergies to medications, food, other products. The outcome of the events was recovered on 11Feb2021.  Information on the lot/batch number has been requested.
Doses administered past the published expiry; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses administered past the published expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information were reported by the reporter
Worsening of peripheral neuropathy with numbness and gait instability starting 3 days after influenza vaccine.  Electrodiagnostic findings consistent with Guillain-Barre syndrome.
Severe and crippling arm pain; Could not lift arm; Chills; High fever; Still have occasional pain in arm at the injection site; Racing heartbeat; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Severe and crippling arm pain), MOBILITY DECREASED (Could not lift arm), PALPITATIONS (Racing heartbeat), CHILLS (Chills) and PYREXIA (High fever) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 048A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sulfonamide allergy. Concomitant products included ASCORBIC ACID, ZINC (VITAMIN C + ZINC), COLECALCIFEROL (VITAMIN D 3), BIOTIN and VIVISCAL ADVANCED HAIR HEALTH for an unknown indication.   On 07-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021 at 10:00 PM, the patient experienced PALPITATIONS (Racing heartbeat). On an unknown date, the patient experienced PAIN IN EXTREMITY (Severe and crippling arm pain), MOBILITY DECREASED (Could not lift arm), CHILLS (Chills), PYREXIA (High fever) and VACCINATION SITE PAIN (Still have occasional pain in arm at the injection site). At the time of the report, PAIN IN EXTREMITY (Severe and crippling arm pain), MOBILITY DECREASED (Could not lift arm), CHILLS (Chills) and PYREXIA (High fever) outcome was unknown, PALPITATIONS (Racing heartbeat) had resolved with sequelae and VACCINATION SITE PAIN (Still have occasional pain in arm at the injection site) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered PALPITATIONS (Racing heartbeat) to be related. No further causality assessments were provided for PAIN IN EXTREMITY (Severe and crippling arm pain), MOBILITY DECREASED (Could not lift arm), CHILLS (Chills), PYREXIA (High fever) and VACCINATION SITE PAIN (Still have occasional pain in arm at the injection site).    Treatment information was not reported.   This case was linked to MOD-2021-059920 (Patient Link).
One week after getting vaccine, patient was diagnosed with URI & Flu.  Now presents with severe body aches for one week, especially of face, shoulder and thighs.  Has a quarter to half dollar size red lump at site of injection today.
INJECTION SITE TENDERNESS/SORENESS; INTERMITTENT HEADACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced injection site tenderness/soreness, and intermittent headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from injection site tenderness/soreness, and intermittent headaches. This report was non-serious.
This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included epilepsy, and asthmatic, and concurrent conditions included non alcohol user, and non smoker, and other pre-existing medical conditions included no known allergies and no drug abuse or illicit drug usage. The patient received covid-19 vaccine  (suspension for injection, intramuscular, batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 08-MAY-2021 13:30 for prophylactic vaccination. No concomitant medications were reported. On 08-MAY-2021, the subject experienced sweating. On 08-MAY-2021, the subject experienced weakness. On 08-MAY-2021, the subject experienced fever. On 08-MAY-2021, the subject experienced tiredness. On 08-MAY-2021, the subject experienced headache. On 09-MAY-2021, the subject experienced body aches. On 10-MAY-2021, the subject experienced throat inflammation. On 10-MAY-2021, the subject experienced pain in ear. On 10-MAY-2021, the subject experienced fluids in ear. On 10-MAY-2021, the subject experienced pain in arm. The action taken with covid-19 vaccine was not applicable. The patient recovered from sweating, and fever on 09-MAY-2021, and had not recovered from headache, weakness, tiredness, body aches, pain in arm, throat inflammation, pain in ear, and fluids in ear. This report was non-serious.
Initial unsolicited case received from a pharmacist on 12 October 2016. This case is linked with 2016SA189772, 2016SA189781, 2016SA189791, 2016SA189792, 2016SA189793, 2016SA189794, 2016SA189795, 2016SA189796, 2016SA189797, 2016SA189798, 2016SA189799, 2016SA189800, 2016SA189801, 2016SA189802, 2016SA189803, 2016SA189804, 2016SA189805, 2016SA189806, 2016SA189807, 2016SA189808, 2016SA189809, 2016SA189810, 2016SA189811, 2016SA189812, 2016SA189813, 2016SA189814, 2016SA189815, 2016SA189816, 2016SA189817, 2016SA189818, 2016SA189819, 2016SA189820, 2016SA189821, 2016SA189822, 2016SA189823, 2016SA189824, 2016SA189825, 2016SA189826, 2016SA189827, 2016SA189828, 2016SA189829, 2016SA189830, 2016SA189831, 2016SA189832, 2016SA189833, 2016SA189834, 2016SA189835, 2016SA189836, 2016SA189837, 2016SA189838, 2016SA189839, 2016SA189840, 2016SA189841, 2016SA189842, 2016SA189843, 2016SA189844, 2016SA189845, 2016SA189846, 2016SA189847, 2016SA189848. This case involves a patients of unspecified age and gender who was vaccinated with FLUZONE (lot number:UI669AA, Expiration date:30 June 2016, site of administration and dose details were not reported) by intramuscular route on 4th October 2016. The medical history and concomitant medications were not reported. The illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions were reported as unknown. On 6 October 2016, two days following vaccination, the patients experienced hematoma, arm still slightly discolored where the shot was given and slight pain, almost feels swollen going up neck on right side of the face (side received shot). The lab test was not reported and the corrective treatment was reported as no. The outcome of the events was reported as unknown. Documents held by sender: none.
About 1 wk a/vax had 8 teeth filled w/amalgam; day p/vax when touched frenchhorn, fingers became swollen & painful; pt was lethargic for @ least 6wks; seen by allergist dx allergic rxn; tx steroids; rheumatoid sx, fatigued, pos ANA titer;
Patient complaining of feeling dizzy like she was going to pass out, heart racing and hands tingling.    Interventions: Patient transported to direct observation area via wheelchair and vitals taken. Patient tachycardic and hypertensive and started to complain that she couldn't breathe and that throat was closing. EpiPen administered, N/C placed and patient was transferred to ED.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 20-DEC-2017, the patient was vaccinated with improperly stored dose of ZOSTAVAX lot number reported as N025701, expiration date reported as 16-DEC-2018 (dose, route and siute of administration were not reported) for prophylaxis. The sterile diluent (manufacturer unknown) was stored properly. The vaccine underwent a temperature excursion of 15 to 46 degrees Fahrenheit. No adverse event was reported. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1712USA014437:
stomach cramps, diarrhea, body aches, swollen lymph nodes under the L armpit .
Information has been received from a physician concerning a 10 year old male who in approximately 1999 was vaccinated with a "standard dose" of VARIVAX (Merck) and MMR II (Merck), when he was one year old. On approximately 18-MAR-2009 the patient experienced shingles with multiple painful lesions on his back. The patient's shingles in his back persisted. The patient sought unspecified medical attention. No further information was available. Follow up information has been received from the physician concerning his patient who on approximately 18-APR-1999 was vaccinated with 0.5 mL (standard dose) of VARIVAX (Merck) and MMR II (Merck). The patient was vaccinated at age of 1 year. There were no concomitant medication. A rash did not occur at the site of injection or elsewhere within 42 days of the vaccination. The patient never had chicken pox. There was not recent exposure to chicken pox or shingles. On 20-MAR-2009, the patient had some redness and his back and arm. On 21-MAR-2009, the patient's parents stated he had vesicles. The patient came into the office on 24-MAR-2009 with a maximum temperature of 99.5. The rash was described as numerous vesicles in T7 dermatome on the R side of back and wrapped around just anterior of mid-axillary line. The patient was started the treatment for the rash. On 25-MAR-2009 a culture was taken and sent the lab on 25-MAR-2009 (results not reported). A direct fluorescent antibody and specimen for PCR were not collected. As of 27-MAR-2009 the patient was not recovered and was currently on treatment. The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild-type (WT) VZV strain or with the Merck vaccine VZV strain. The sample of the lesion was collected on 25-MAR-2009. The sample was taken from a vesicular lesion. The PCR results for the specimen from vesicular lesion identified the presence of WT VZV. Additional information is not expected.
9cm localized rx rt arm-indurated area;Cefzil 250mg po bid x 10 days given;recheck in 2-3 days;
Information has been received from a registered nurse concerning a female who was vaccinated with a dose of GARDASIL (lot#, route and site of administration not reported). Subsequently the patient experienced syncope episodes after vaccination. Unspecified medical attention was sought. On an unspecified date the patient recovered. This is one of several reports from the same source. Additional information has been requested.
From a telephone call received on 12/03/01, it was reported that a patient was administered Fluzone on 11/05/01 in her left deltoid. The next morning, patient awoke with bilateral conjuctivitis. The eye doctor dismissed viral conjuctivitis. She also had facial flushing, swelling and itching of face and neck. The doctor prescribed Allegra and Opcona eye drops for eye allergy. All symptoms resolved within 72 hours.
NAUSEA; STARTED MENSTRUAL CYCLE 1 WEEK EARLY; DIARRHEA; PERIOD CRAMPS; FLU LIKE SYMPTOMS; BODY ACHE; This spontaneous report received from a patient concerned a 41 year old white ,Not Hispanic or Latino female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805020, and batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 05-MAR-2021 01:45 to Left Arm for prophylactic vaccination. No concomitant medications were reported. On 06-MAR-2021 03:00, the subject experienced flu like symptoms. On 06-MAR-2021 03:00, the subject experienced body ache. Treatment medications included: ibuprofen. On 07-MAR-2021 03:00, the subject experienced period cramps. On 07-MAR-2021 05:00, the subject experienced started menstrual cycle 1 week early. On 07-MAR-2021 05:00, the subject experienced diarrhea. On 07-MAR-2021 07:40, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the period cramps, started menstrual cycle 1 week early, flu like symptoms, body ache, diarrhea and nausea was not reported. This report was non-serious.     .
Patient came with Mom requesting Covid 19 Moderna shot and received first dose on 11/6/21. Patient's birthdate is 12/31/2003. No prior medical history. Patient came in for second shot on 12/4/21 and then was discovered she was 17yo and 10mo when received the first shot. Patient has a sore arm after the shot and did not complaint any major adverse event.
Varivax was given on 4-3-08, patient developed large local reaction on that night.  Area red, warm to the touch and raised.  Patient has had the same reaction on 8-19-04, age 25 months at the time of first Varivax.  Mom had forgotten 11 x 13 cm.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Mar2021 as dose 1, single (Lot number: EN6208), in left arm, on 13Apr2021 as dose 2, single (Lot number: EW0158), in left arm, on 08Oct2021 as dose 3 (booster), single (Lot number: 30155BA), in left arm and on 28Apr2022 as dose 4 (booster), single (Lot number: FJ4989), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing), notes: Other medical history: Hypertension. Concomitant medication(s) included: LISINOPRIL; HCTZ. Past drug history included: Codeine, reaction(s): "Known allergies: Codeine", notes: Known allergies: Codeine; Emycin, reaction(s): "Known allergies: Emycin", notes: Known allergies: Emycin. The following information was reported: COVID-19 (medically significant) with onset Jul2022, outcome "recovering", VACCINATION FAILURE (medically significant), outcome "recovering" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Anti viral drug paxlovid for COVID 19 treatment started from 01Jul2022 until 05Jul2022.
seizure-like activity Pt had 3 seizures. After first seizure, pt was taken to ED, had 2 additional seizures requiring Ativan to subdue the seizure. He was then started on Keppra.
Soreness at injection site on day 2 then on day 6 I had a swollen lymph node in my armpit area and then next day on day 7 a red, itchy and swollen rash on my arm with pain started and is still present on 1/30/21.  I went to urgent care to have my arm checked and NP put me on antibiotics  keflex 500mg twice a day x7 days saying it was a skin infection.
Smelling smoke all of the time for 8 days -  when there isn't any.  Slight flu symptoms
Incorrect dose, given Tdap, should have been DTaP. No adverse reactions reported.
(Moderna) Vaccine was given beyond the refrigeration use; (Moderna) Vaccine was given beyond the refrigeration use; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use). On an unknown date, the patient experienced PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use). At the time of the report, EXPIRED PRODUCT ADMINISTERED ((Moderna) Vaccine was given beyond the refrigeration use) and PRODUCT STORAGE ERROR ((Moderna) Vaccine was given beyond the refrigeration use) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. The vial was initially stored in the refrigerator on 02-Jun-2022. The vial does not undergo any temperature excursions. No treatment medications was reported.